Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Interferon")

Filter

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Origin

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 36307

  • Page / 1453

Export

Selection :

  • and

Characterization of interferon induced in murine macrophage cultures by 10-carboxymethyl-9-acridanoneBREHM, G; STORCH, E; KIRCHNER, H et al.Natural immunity and cell growth regulation. 1986, Vol 5, Num 1, pp 50-59, issn 0254-7600Article

Putting the brakes on the anti-viral response: negative regulators of type I interferon (IFN) productionRICHARDS, Kathryn H; MACDONALD, Andrew.Microbes and infection. 2011, Vol 13, Num 4, pp 291-302, issn 1286-4579, 12 p.Article

Transcriptional upregulation of interferon-induced protein kinase, PKR, in breast cancerNUSSBAUM, Jean M; MAJOR, Marian; GUNNERY, Shobha et al.Cancer letters. 2003, Vol 196, Num 2, pp 207-216, issn 0304-3835, 10 p.Article

Evaluation of the in vitro production of interferon γ and other lymphokines in uremic patientsYOUSEFI, S; VAZIRI, N. D; CARANDANG, G et al.Proceedings of the Society for Experimental Biology and Medicine. 1987, Vol 184, Num 2, pp 179-185, issn 0037-9727Article

Synthesis and biological properties of chimeric interferon-α2b peptidesPENA, Clara; BLANK, Viviana C; MARINO, Veronica J et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 7, pp 1144-1149, issn 0196-9781, 6 p.Article

Reduction in p48-ISGFγ levels confers resistance to Interferon-α2a in MHCC97 cellsWU, Wei-Zhong; SUN, Hui-Chuan; GAO, Yan-Qin et al.Oncology. 2004, Vol 67, Num 5-6, pp 428-440, issn 0030-2414, 13 p.Article

Factor determining the antigenic type of interferons produced in human lymphoblastoid cell linesMATSUOKA, H; IMANISHI, J; HOSHINO, S et al.Biken journal. 1984, Vol 27, Num 4, pp 153-159, issn 0006-2324Article

Medizinische und kommerzielle Aspekte der menschlichen Interferone = Aspects médicaux et commerciaux des interférons humains = Medical and commercial aspects of human interferonsVON EICHBORN, J. F.Arzneimittel-Forschung. 1986, Vol 36, Num 2, pp 279-282, issn 0004-4172Article

Assay of interferonsFORTI, R. L; SCHUFFMAN, S. S; FLEISCHMANN, W. R. JR et al.Methods in enzymology. 1986, Vol 119, pp 533-593, issn 0076-6879Article

Purifications of interferonsTARNOWSKI, S. J; ROY, S. K; CHIEN-HWA CHEN et al.TARNOWSKI, S. J; Methods in enzymology. 1986, Vol 119, pp 153-230, issn 0076-6879Article

Enzymes in interferon actionFLOYD-SMITH, G; LENGYEL, P; IMAI, J et al.LENGYEL, P; Methods in enzymology. 1986, Vol 119, pp 489-529, issn 0076-6879Article

Measurement of effect of interferons on drug metabolismSONNENFELD, G; NERLAND, D. E; MANNERING, G. J et al.Methods in enzymology. 1986, Vol 119, pp 715-725, issn 0076-6879Article

Procedures for studying the interferon receptor and uptake of interferonLANGER, J. A; PESTKA, S; GUPTA, S. L et al.PESTKA, S; Methods in enzymology. 1986, Vol 119, pp 305-356, issn 0076-6879Article

Interleukins, interferon and rheumatic diseaseTALAL, N.Clinics in rheumatic diseases. 1985, Vol 11, Num 3, pp 633-644, issn 0307-742XArticle

Current view on the perspectives of interferon therapyBORECKY, C.Acta virologica (English ed.). 1986, Vol 30, Num 2, pp 161-169, issn 0001-723XArticle

Radiolabeling of interferonsSARKAR, F. H; GUPTA, S. L; PESTKA, S et al.Methods in enzymology. 1986, Vol 119, pp 263-301, issn 0076-6879Article

Inductions of interferons. A: Human interferons. ― B: Non-human interferonsKAUPPINEN, H.-L; HIRVONEN, S; YIP, Y. K et al.Methods in enzymology. 1986, Vol 119, pp 27-149, issn 0076-6879Article

Priming of bovine interferonsLEFKOWITZ, S. S; REYES LUNA, V. E.Intervirology. 1984, Vol 21, Num 4, pp 221-223, issn 0300-5526Article

Interferons : The pathways of discovery. II. Immunomodulatory, In vivo and applied aspectsBILLIAU, Alfons.Journal of clinical virology. 2007, Vol 39, Num 4, pp 241-265, issn 1386-6532, 25 p.Article

Interferons: what future?SCOTT, G. M.Trends in biotechnology (Library edition). 1986, Vol 4, Num 4, pp 78-79, issn 0167-9430Article

The clinical use of interferonsRINGENBERG, Q. S; ANDERSON, P. C.International journal of dermatology. 1986, Vol 25, Num 5, issn 0011-9059, 294Article

Interferon treatment of human neoplasiaSTRANDER, H.Advances in cancer research. 1986, Vol 46, issn 0065-230X, X-265 pSerial Issue

The physiological interferon response. IV: Production of interferon by the perfused human placenta at termBOCCI, V; PAULESU, L; RICCI, M. G et al.Proceedings of the Society for Experimental Biology and Medicine. 1985, Vol 180, Num 1, pp 137-143, issn 0037-9727Article

Simulation mathématique de l'influence des inducteurs d'interféron sur le développement des infections viralesCHIZHOV, N. P; CHRUNOSOV, E. V.Voprosy virusologii. 1988, Vol 33, Num 1, pp 94-98, issn 0507-4088Article

Current status of recombinant interferon in cancer therapy, congress, Los Angeles CA May 3, 1986Cancer. 1987, Vol 59, Num 3, pp 633-674, issn 0008-543X, suppl. 2Conference Proceedings

  • Page / 1453